Nan Fung Group Holdings LTD Kymera Therapeutics, Inc. Transaction History
Nan Fung Group Holdings LTD
- $101 Million
- Q4 2024
A detailed history of Nan Fung Group Holdings LTD transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Nan Fung Group Holdings LTD holds 30,875 shares of KYMR stock, worth $914,517. This represents 1.23% of its overall portfolio holdings.
Number of Shares
30,875
Previous 10,875
183.91%
Holding current value
$914,517
Previous $514,000
141.63%
% of portfolio
1.23%
Previous 0.5%
Shares
4 transactions
Others Institutions Holding KYMR
# of Institutions
187Shares Held
60.3MCall Options Held
49.6KPut Options Held
17K-
Price T Rowe Associates Inc Baltimore, MD6.87MShares$203 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$178 Million2.67% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$153 Million7.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.15MShares$153 Million3.02% of portfolio
-
Atlas Venture Life Science Advisors, LLC4.9MShares$145 Million32.49% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $1.62B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...